Uploaded January 2026 | Updated September 2026, 2 days ago
We look at how a $1,000-a-month injectable drug created the incentive to develop a much cheaper pill that does the same job. Instead of price caps or mandates, we show how high prices motivate entrepreneurs to innovate, expand access, and drive costs down through competition.
We look at how a $1,000-a-month injectable drug created the incentive to develop a much cheaper pill that does the same job. Instead of price caps or mandates, we show how high prices motivate entrepreneurs to innovate, expand access, and drive costs down through competition.
